Genomic Sequencing in Clinical TrialsIn this article, researchers from Northwestern University Feinberg review the current and future directions of clinical research with respect to genomic sequencing.
Diffusion Pharmaceuticals Begins Clinical Trial for Treatment of Primary Brain CancerCompany announced clinical trial testing of its lead drug candidate trans sodium crocetinate (TSC) as a first-line treatment for newly diagnosed primary brain cancer, also known as glioblastoma or GBM.
BioSante Pharmaceuticals Reports Positive LibiGel Safety Data Review for Phase III ProgramBioSante Pharmaceuticals Reports Positive LibiGel Safety Data Review for Phase III Program.
Insmed Incorporated Provides Update on Clinical Program for ARIKACE®The Company is proceeding with phase 2 clinical trial in patients with non-tuberculous mycobacteria lung disease, as well as the previously planned European registration phase 3 clinical study of ARIKACE in Cystic Fibrosis patients with Pseudomonas aeruginosa lung infections.
Results From Phase I Clinical Trials Demonstrate Positive Safety Data of AVI BioPharma's RNA-Based TherapeuticsAVI BioPharma, Inc. have announced positive safety results from all six dose cohorts in the single ascending dose studies of AVI-6002 and AVI-6003, AVI's lead drug candidates being evaluated for the treatment of Ebola virus and Marburg virus, respectively.
Titan Pharmaceuticals Announces Positive Results of Six-Month Open-Label Safety Retreatment Study of ProbuphinePatients report high satisfaction, decreased opioid dependence problems and significant overall improvement with Probuphine; NDA expected to be filed in 3Q 2012.
Anacor Pharmaceuticals Announces Preliminary Results from Two Safety StudiesAN2728 studies provide positive results, ointment well tolerated on large body surfaces and sensitive skin.
Rapid Bone Loss Possible Side Effect of Anti-Obesity DrugResearch from UT Southwestern Medical Center has raised concern about the safe use of fibroblast growth factor 21.
Anacor Pharmaceuticals Announces Its Partner GSK Voluntarily Paused Clinical TrialsTrials paused due to a recently identified microbiological finding in a small number of patients in the Phase 2b trial of GSK '052 for the treatment of complicated urinary tract infections (cUTI).
NIH-funded HIV Clinical Research Sites to Join Pediatric Tuberculosis Vaccine StudySeveral U.S. government-funded HIV/AIDS clinical research sites in Africa will join other collaborators in an ongoing clinical trial testing an investigational tuberculosis vaccine in infants at risk for TB infection.
